Physician

Dan Gavrila, MD

According to 2025 Medicare claims, Dan Gavrila, MD (NPI: 1992818678) practices interventional cardiology in the Wausau, WI market, with the plurality of this provider's patient population coming from Marathon, WI. This provider's primary affiliated billing organization is MCHS HOSPITALS INC (NPI: 1992336655; TIN: 810977948) and primary practice location at 54476-5220.

Gavrila's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,387 traditional Medicare patients, billed 3,694 HCPCS/CPT codes, and received $152,248 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 1,499 prescription claims across 334 beneficiaries totaling $197,974 in drug costs, led by Eliquis (Apixaban). Open Payments data shows 2 records totaling $184. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $217,736 to $152,248. In contrast, Part D prescription costs have risen steadily, from $86,301 to $197,974. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$139K$278K2015 Medicare payment: $217,736 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $261,501 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $278,118 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $239,899 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $266,648 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $208,991 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $187,542 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $168,489 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $176,168 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $152,248 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,6513,817$217,736
20161,6804,337$261,501
20171,4034,264$278,118
20181,2593,693$239,899
20191,4634,360$266,648
20201,3873,864$208,991
20211,2693,290$187,542
20221,2693,351$168,489
20231,4473,950$176,168
20241,3873,694$152,248

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$104K$208K2015 Drug cost: $86,301 (USD; Tot_Drug_Cst)2016 Drug cost: $125,491 (USD; Tot_Drug_Cst)2017 Drug cost: $140,178 (USD; Tot_Drug_Cst)2018 Drug cost: $183,310 (USD; Tot_Drug_Cst)2019 Drug cost: $197,606 (USD; Tot_Drug_Cst)2020 Drug cost: $151,253 (USD; Tot_Drug_Cst)2021 Drug cost: $144,185 (USD; Tot_Drug_Cst)2022 Drug cost: $197,151 (USD; Tot_Drug_Cst)2023 Drug cost: $208,281 (USD; Tot_Drug_Cst)2024 Drug cost: $197,974 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152921,803$86,301
20163251,752$125,491
20172971,676$140,178
20182771,729$183,310
20192871,612$197,606
20202741,278$151,253
20212451,221$144,185
20222721,459$197,151
20233031,447$208,281
20243341,499$197,974

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
93306Ultrasound of heart with color-depicted blood flow, rate, direction and valve function291315$53
93295Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days103165$25
93294Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days215332$19
93297Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days130355$18
93010Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only639809$6

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
EliquisApixaban713,963$76,258
XareltoRivaroxaban381,710$30,849
Repatha SureclickEvolocumab361,238$24,265
Repatha SyringeEvolocumab19952$18,804
EntrestoSacubitril/Valsartan17570$12,697

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.2$184Boston Scientific Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Dan Gavrila, MD?

Tedicare shows public-source Medicare data for Dan Gavrila, MD (NPI 1992818678), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Dan Gavrila, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Dan Gavrila, MD?

Dan Gavrila, MD is linked to MCHS HOSPITALS INC (billing NPI 1992336655) in the available physician profile data.

Does Dan Gavrila, MD have Open Payments data?

Dan Gavrila, MD has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.